These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 21415922

  • 1. Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).
    Bönner G, Landers B, Bramlage P.
    Vasc Health Risk Manag; 2011; 7():85-95. PubMed ID: 21415922
    [Abstract] [Full Text] [Related]

  • 2. Candesartan cilexetil/hydrochlorothiazide treatment in high-risk patients with type 2 diabetes mellitus and microalbuminuria: the CHILI T2D study.
    Ketelhut R, Bramlage P.
    Clin Drug Investig; 2010; 30(5):301-11. PubMed ID: 20384386
    [Abstract] [Full Text] [Related]

  • 3. Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
    Lee HY, Hong BK, Chung WJ, Lee BK, Lee SH, Jeon DW, Ahn YK, Kim D, Park CK, Kim SH, Jung HO, Kim BO, Choi D.
    Clin Ther; 2011 Aug; 33(8):1043-56. PubMed ID: 21831438
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care.
    Edes I, Multicentre Study Group.
    Clin Drug Investig; 2009 Aug; 29(5):293-304. PubMed ID: 19366271
    [Abstract] [Full Text] [Related]

  • 5. Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.
    Mengden T, Uen S, Bramlage P.
    Vasc Health Risk Manag; 2009 Aug; 5():1043-58. PubMed ID: 20057897
    [Abstract] [Full Text] [Related]

  • 6. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB, Jarvis B.
    Drugs; 2002 Aug; 62(5):787-816. PubMed ID: 11929332
    [Abstract] [Full Text] [Related]

  • 7. Low dose of hydrochlorothiazide, in combination with angiotensin receptor blocker, reduces blood pressure effectively without adverse effect on glucose and lipid profiles.
    Fujiwara W, Izawa H, Ukai G, Yokoi H, Mukaide D, Kinoshita K, Morimoto S, Ishii J, Ozaki Y, Nomura M.
    Heart Vessels; 2013 May; 28(3):316-22. PubMed ID: 22447467
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
    McInnes GT, O'Kane KP, Istad H, Keinänen-Kiukaanniemi S, Van Mierlo HF.
    J Hum Hypertens; 2000 Apr; 14(4):263-9. PubMed ID: 10805052
    [Abstract] [Full Text] [Related]

  • 9. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B, Gerwe M, Braun M, Funken C.
    Arzneimittelforschung; 2005 Apr; 55(9):505-13. PubMed ID: 16229114
    [Abstract] [Full Text] [Related]

  • 10. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
    Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL.
    Am J Cardiol; 1999 Aug 01; 84(3):289-93. PubMed ID: 10496437
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka N.
    Clin Ther; 2012 Apr 01; 34(4):838-48. PubMed ID: 22440192
    [Abstract] [Full Text] [Related]

  • 12. A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy.
    Campbell M, Sonkodi S, Soucek M, Wiecek A.
    Clin Exp Hypertens; 2001 May 01; 23(4):345-55. PubMed ID: 11349825
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other Angiotensin-receptor blockers.
    Fuenfstueck R, Hempel RD, Ansari A, Weidinger G, Klebs S.
    Adv Ther; 2005 May 01; 22(3):263-77. PubMed ID: 16236687
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide.
    Ohma KP, Milon H, Valnes K.
    Blood Press; 2000 May 01; 9(4):214-20. PubMed ID: 11055474
    [Abstract] [Full Text] [Related]

  • 15. Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension.
    Oparil S.
    Am J Cardiol; 1999 Nov 18; 84(10A):35S-41S. PubMed ID: 10588093
    [Abstract] [Full Text] [Related]

  • 16. Candesartan cilexetil 32 mg/hydrochlorothiazide 25 mg in unselected patients with high or very high cardiovascular risk: efficacy, safety, and metabolic impact.
    Bramlage P, Buhck H, Zemmrich C.
    Clin Drug Investig; 2014 Apr 18; 34(4):241-9. PubMed ID: 24482018
    [Abstract] [Full Text] [Related]

  • 17. Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice.
    Bramlage P, Zemmrich C, Ketelhut R, Wolf WP, Fronk EM, Schmieder RE.
    Vasc Health Risk Manag; 2013 Apr 18; 9():475-83. PubMed ID: 24039432
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT, Hung YJ, Chen JF, Wang CY, Lee WJ, Sheu WH.
    Clin Ther; 2012 Aug 18; 34(8):1735-50. PubMed ID: 22784975
    [Abstract] [Full Text] [Related]

  • 19. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with Candesartan/HCTZ].
    Bramlage P, Schönrock E, Odoj P, Wolf WP, Funken C.
    MMW Fortschr Med; 2008 Jan 17; 149 Suppl 4():172-81. PubMed ID: 18402243
    [Abstract] [Full Text] [Related]

  • 20. Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia
.
    Katsube Y, Hira D, Tsujimoto M, Koide H, Minegaki T, Ikeda Y, Morita SY, Nishiguchi K, Terada T.
    Int J Clin Pharmacol Ther; 2018 Jul 17; 56(7):328-336. PubMed ID: 29792394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.